Body Composition Analyzers Market Expected to Reach $618.71 Million by 2030

According to a new report published by Allied Market Research, titled, “Body Composition Analyzers Market by Product, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030,” The global body composition analyzers market size generated $398.22 million in 2020, and is projected to reach $618.71 million by 2030, growing at a CAGR of 4.5% from 2021 to 2030.

Body composition is the ratio of fat and fat-free mass in the body. Body composition analysis is required to measure and to assess health and fitness level of obese patients or other fitness-conscious people. Body composition analyzer is a device, which provides detailed information for personalized health or fitness consultations. Furthermore, it is used to strategize an exercise plan in terms of one’s need to lose fat or build muscle. Multiple ways are available to measure body composition, and each method has advantages and disadvantages.

On the basis of product, the market is segmented into bio-impedance analyzer, dual energy X-ray absorptiometry equipment, skinfold calipers, air displacement plethysmography equipment, and hydrostatic weighing equipment. The bio-impedance analyzer segment was the major revenue contributor in 2020 and is anticipated to continue this trend during the forecast period, owing to the fact that bioimpedance analysis is a noninvasive, low-cost, and a commonly used approach for body composition assessment for the clinical condition. Thus, bio-impedance analyzers are affordable for fitness centers and home users.

On the basis of end user, the body composition analyzers market is categorized into hospitals, fitness clubs & wellness centers, and home users. The home users segment is projected to show fastest growth during the forecast period, due to rise in health awareness and surge in keeping fitness equipment at home all across the world.

This report provides comprehensive competitive analysis and profiles of prominent market players such as Bodystat Ltd., COSMED Srl, General Electric Company (GE Healthcare), Hologic, Inc., Inbody Co., Ltd., Omron Corporation, RJL Systems, Inc., SELVAS AI Inc. (Jawon Medical Co., Ltd.), Seca GmbH & Co.Kg., and Tanita Corporation.

Key Findings Of The Study

• Based on product, the bio-impendence segment is expected to experience rapid growth in the market and is projected to grow at a CAGR of 5.6% from 2021 to 2030.
• By end user, the fitness clubs & wellness centers segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.

North America generated the highest revenue in the global body composition analyzers market in 2020, accounting for near about 4.2% of the global market.